Best Antithrombotic Therapy in Patients With Acute Venous ThromboEmbolism While Taking Antiplatelets
A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 1400 participants.
Also called NCT05627375
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 1,400 participants
- Registry
-
NCT05627375
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- France
- Registry status
- Recruiting
Technical summary
Registry record NCT05627375. Randomized; no masking; primary purpose treatment. Start 2023-08-16 (actual); primary completion 2027-12 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Best Antithrombotic Therapy in Patients With Acute Venous ThromboEmbolism While Taking Antiplatelets
- Acronym
- BAT-VTE
- Condition
- Venous Thromboembolic Disease
- Intervention (Drug)
- Full-dose anticoagulant therapy (AC)
- Intervention (Drug)
- Antiplatelet therapy (AP)
- Lead sponsor
- Centre Hospitalier Universitaire de Saint Etienne
- Collaborator
- Ministry of Health, France
Record details
- Record id
cardio:ct-nct05627375- Content hash
2c93ed2a8e39b500ca04aa30e32beb7922c89cecdb9e0b0959451b51f9a701a8